Spectrum Pharmaceuticals Inc expected to post a loss of 6 cents a share - Earnings Preview

Spectrum Pharmaceuticals

08/05/2023 14:20

* Spectrum Pharmaceuticals Inc  SPPI.OQ   SPPI.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 10 (estimated). 
    * The Henderson Nevada-based  company is expected to report
revenue of $10.968 million, according to the mean estimate from
5 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Spectrum
Pharmaceuticals
Inc is for a loss of 6 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $1.14​, above​ its last closing price
of $1.09. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.11       -0.11      -0.05     Beat    53.7
 Sep. 30 2022  -0.15       -0.15      -0.12     Beat    18.6
 Jun. 30 2022  -0.15       -0.16      -0.17     Missed  -7.6​
 Mar. 31 2022  -0.20       -0.19      -0.08     Beat    58.3
 ​​Dec.                    -0.21      -0.26     Missed  -21.5
 31 2021                                                
 Sep. 30 2021  -0.28       -0.28      -0.21     Beat    25​
 Jun. 30 2021  -0.25       -0.25      -0.32     Missed  -25.5
 Mar. 31 2021  -0.30       -0.31      -0.25     Beat    20.6
 This summary was machine generated May 8 at 13:20 GMT.  All
figures in US dollars  unless otherwise stated